We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Seek Clarification In Cellular, Gene Drug Guidance
Drugmakers Seek Clarification In Cellular, Gene Drug Guidance
March 8, 2013
Drugmakers are calling for clarification, consolidation and BLA-specific advice in comments to the FDA’s draft guidance on preclinical assessments of cellular and gene therapy drugs.